University of Kansas Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kansas Medical Center sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
University of Kansas Medical Center: 408 sponsored US clinical trials, 93 recruiting.
University of Kansas Medical Center sponsors 408 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 252 completed. 28 of these trials are in Phase 3-4 (later-stage) and 85 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smoking Cessation, with 9 trials.
Top-decile sponsor footprint
University of Kansas Medical Center ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
252 of 275 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 8 of 9
Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research
NCT01900288
Central Mechanism of Manual Therapy for Low Back Pain
NCT03078114
Sensory Supported Swimming for Children With ASD
NCT02747459
The Effects of Altering Physical Activity on Cardiometabolic Health
NCT01879059
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
NCT01660191
Dairy Intake and Brain Health in Aging
NCT02245035
Neuroimaging Study of Factors Related to Exercise
NCT02010463
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
NCT01835691
Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)
NCT01419691
Rural Women Connecting for Better Health
NCT01441011
Flaxseed Lignan (Brevail)
NCT01396369
Motivational Interviewing (MI) for African Americans With Peripheral Arterial Disease (PAD)
NCT01321086
Evaluation of Intravenous Ascorbic Acid
NCT01833351
Changing Talk to Reduce Resistiveness to Care
NCT01324219
Hospitalized Smokers
NCT01305928
A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
NCT01304602
Impact of Vitamin D Therapies on Chronic Kidney Disease
NCT01222234
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma
NCT01171092
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
NCT01174277
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458
A Research Study Looking at Specific Tissue of the Umbilical Cord
NCT01166776
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
NCT01174940
Comparison of Apnea Tolerance in Two Positions of Patients With BMI 30-40
NCT03056820
Proposal and Clinical Evaluation of a Comprehensive Airway Exam Score
NCT03060187
Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine
NCT01022021
Axillary Reverse Mapping
NCT01381315
Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes
NCT00972452
Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression
NCT00944047
Qigong Exercise May Benefit Patients With Fibromyalgia
NCT01333566
Disease Management for Smoking Cessation
NCT00440115
A Study to Evaluate the Effectiveness of 5-Azacitidine and Bevacizumab in Advanced Renal Cell Carcinoma
NCT00934440
Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
NCT00921115
Efficacy of Methotrexate in Myasthenia Gravis
NCT00814138
Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
NCT00759642
Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer
NCT00853996
Evaluate Rituximab in Obtaining PCR (Polymerase Chain Reaction) Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma
NCT00856245
Physical Activity and Glycemic Control
NCT00881972
Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis
NCT00814333
Evaluation of Apnea Tolerance in Bariatric Patients Following Rapid-sequence Induction of Anesthesia
NCT03056807
Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer
NCT01189370
Effect of Intraarticular Steroids on Bone Turnover in Osteoarthritis
NCT00682357
Dietary Control Alone Versus Dietary Control Plus Use of Proton Pump Inhibitors to Treat Pediatric Hoarseness
NCT00637416
Multi-day Doses in Prevention of Nausea and Emesis
NCT00600353
Communication With in Vitro Fertilization (IVF) Patients About Risks
NCT00722618
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
NCT00591149
Exercise, Statins, and the Metabolic Syndrome
NCT01700530
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT00443261
fMRI Study Examining Effects of D-cycloserine in Specific Phobia
NCT00591825
Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy
NCT00442520
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis
NCT00595621
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 45 |
| Phase 3 | 9 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Kansas Medical Center pipeline
93 recruiting of 408 indexed (23% open); 252 completed (62%).
Phase mix: 28 late (III/IV) vs 85 early (I/II) (early-phase heavy).
Top condition: Smoking Cessation (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kansas Medical Center: open-pipeline peers nationwide
Peers matched on 408 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- Takeda · 408 trials · 12% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Texas at Austin · 23% recruiting · 257 trials
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
Related
What to do with this University of Kansas Medical Center page
408 registered trials is a research-attention snapshot, not an endorsement of University of Kansas Medical Center or any single study.
- 93 of University of Kansas Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Smoking Cessation is the condition University of Kansas Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Kansas Medical Center pipeline card: 408 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.